Sun et al. [142] designed an IVD carrier incorporating polydopamine nanoparticles loaded with connective tissue growth factor (CTGF) and TGF-β3, which were combined with BMSCs to regenerate NP and AF. The gene discussed is CCN2; the disease is atrial fibrillation.